{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:27:06Z","timestamp":1767706026919},"posted":{"date-parts":[[2024,9,8]]},"group-title":"In Review","reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,8,1]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n Mesenchymal neoplasms composed of vascular, smooth muscle, and adipocytic components are uncommon in the nasal cavity. While angioleiomyoma (AL) is a smooth muscle tumor in the Head &amp; Neck WHO classification, it is considered of pericytic origin in the Skin as well as Soft Tissue and Bone classifications. For nasal AL with an adipocytic component, the terms AL with adipocytic differentiation and angiomyolipoma (AML) have been applied, among others. AML is a type of perivascular epithelioid cell tumor (PEComa), most often arising in the kidney, sometimes associated with the tuberous sclerosis complex (TSC). It is uncertain whether nasal cavity AML and AL are best considered hamartomas or neoplasms, as their genetics are largely unexplored.\nMethods\n We performed a multi-institutional retrospective study of nasal cavity mesenchymal lesions. Patient demographics, clinical histories, and histologic and immunohistochemical findings were collected. DNA and RNA were extracted from formalin-fixed, paraffin-embedded tissue and analyzed by SNP-based chromosomal microarray, targeted RNA fusion sequencing, and whole-exome sequencing.\nResults\n Fifteen lesions (3 to 42 mm) were identified predominantly in male (87%) patients with a median age of 60. Patients typically presented with obstructive symptoms, and none had a history of TSC. One AL was a recurrence from six years prior; 11 cases showed no recurrence (median 4.7 years, range: 0.88\u201312.4). Morphologically, 11 AMLs contained 30\u201380% smooth muscle, 10\u201325% vasculature, and 2\u201360% adipose tissue, while four ALs contained 70\u201380% smooth muscle and 20\u201330% vasculature. Other histologic observations included surface ulceration, vascular thrombosis, chronic inflammation, and myxoid change; no well-developed epithelioid cell morphology was identified. Immunohistochemically, all cases were positive for smooth muscle markers (actin and\/or desmin) and negative for melanocytic markers. Molecular analysis revealed loss of 3p and 11q in a single AML. No other known pathogenic copy number or molecular alterations were seen, including in <italic>TSC1<\/italic>\/<italic>2<\/italic>, <italic>TFE3<\/italic>, or <italic>NOTCH2<\/italic>.\nConclusion\n Nasal cavity AML lacks morphologic, immunophenotypic, and genetic features of PEComa family AMLs. The significant histologic overlap between nasal AML and AL without distinguishing molecular features in either entity suggests \u201csinonasal angioleiomyoma with adipocytic differentiation\u201d may be the most appropriate terminology for hybrid vascular and smooth muscle lesions containing adipocytic components.<\/p>","DOI":"10.21203\/rs.3.rs-4843357\/v1","type":"posted-content","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T20:01:34Z","timestamp":1725825694000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study"],"prefix":"10.21203","author":[{"given":"Victoria M.","family":"Jones","sequence":"first","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lester D. R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Head and Neck Pathology Consultations"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Pettus","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C.","family":"Green","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel A.","family":"Lefferts","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parth S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Tsongalis","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipti P.","family":"Sajed","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Guilmette","sequence":"additional","affiliation":[{"name":"H\u00f4pital Charles-Lemoyne, University of Sherbrooke"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Fisch","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Tafe","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy A.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1055\/s-0033-1364173","article-title":"Angioleiomyoma of the Nasal Cavity","volume":"18","author":"Arruda MM","year":"2014","unstructured":"Arruda MM, Monteiro DY, Fernandes AM, et al. Angioleiomyoma of the Nasal Cavity. Int Arch Otorhinolaryngol. 2014;18(4):409\u201311. 10.1055\/s-0033-1364173.","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"NP72","DOI":"10.1177\/0145561321991322","article-title":"Nasal Septal Angioleiomyoma and Septal Sinus Surgery: A Review of 2 Cases","volume":"102","author":"Noreikaite G","year":"2023","unstructured":"Noreikaite G, Kim SA, Horcher A. Nasal Septal Angioleiomyoma and Septal Sinus Surgery: A Review of 2 Cases. Ear Nose Throat J. 2023;102(2):NP72\u20135. 10.1177\/0145561321991322.","journal-title":"Ear Nose Throat J"},{"issue":"5","key":"ref3","doi-asserted-by":"publisher","first-page":"NP222","DOI":"10.1177\/0145561319878302","article-title":"Sinonasal Angioleiomyoma With Adipocyte Differentiation: Clinicopathologic Study of 2 Cases and Review of the Literature","volume":"100","author":"D\u2019Aguanno V","year":"2021","unstructured":"D\u2019Aguanno V, Ralli M, De Vincentiis L, et al. Sinonasal Angioleiomyoma With Adipocyte Differentiation: Clinicopathologic Study of 2 Cases and Review of the Literature. Ear Nose Throat J. 2021;100(5):NP222\u20134. 10.1177\/0145561319878302.","journal-title":"Ear Nose Throat J"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/s0196-0709(98)90066-7","article-title":"Vascular leiomyoma with abundant adipose cells of the nasal cavity","volume":"19","author":"Murono S","year":"1998","unstructured":"Murono S, Ohmura T, Sugimori S, Furukawa M. Vascular leiomyoma with abundant adipose cells of the nasal cavity. Am J Otolaryngol. 1998;19(1):50\u20133. 10.1016\/s0196-0709(98)90066-7.","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12105-015-0636-y","article-title":"Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature","volume":"9","author":"Agaimy A","year":"2015","unstructured":"Agaimy A, Michal M, Thompson LDR, Michal M. Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature. Head Neck Pathol. 2015;9(4):463\u201373. 10.1007\/s12105-015-0636-y.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/hed.2880160312","article-title":"Angiomyolipoma of the nasal cavity: case report and review of the literature","volume":"16","author":"Gatalica Z","year":"1994","unstructured":"Gatalica Z, Lowry LD, Petersen RO. Angiomyolipoma of the nasal cavity: case report and review of the literature. Head Neck. 1994;16(3):278\u201381. 10.1002\/hed.2880160312.","journal-title":"Head Neck"},{"issue":"10","key":"ref7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamaoto.2013.4397","article-title":"A man with recurrent right-sided epistaxis. Angiomyolipoma (AML) of the nasal cavity","volume":"139","author":"Iwata AJ","year":"2013","unstructured":"Iwata AJ, Friedmann DR, Kaplan J, Wang BY, Lebowitz RA. A man with recurrent right-sided epistaxis. Angiomyolipoma (AML) of the nasal cavity. JAMA Otolaryngol Head Neck Surg. 2013;139(10):1067\u20138. 10.1001\/jamaoto.2013.4397.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1177\/014556131509400713","article-title":"Maxillary sinus angiomyolipoma: A case report and overview","volume":"94","author":"Weindling SM","year":"2015","unstructured":"Weindling SM, Menke DM, Bolger WE. Maxillary sinus angiomyolipoma: A case report and overview. Ear Nose Throat J. 2015;94(7):E1\u20134. 10.1177\/014556131509400713.","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12105-020-01224-1","article-title":"Angiomyolipoma of the Nasal Cavity: A Distinct Entity. A Case Report and Literature Review","volume":"15","author":"Wang L","year":"2020","unstructured":"Wang L, Leng B, Liu L. Angiomyolipoma of the Nasal Cavity: A Distinct Entity. A Case Report and Literature Review. Head Neck Pathol. 2020;15(2):709\u201314. 10.1007\/s12105-020-01224-1.","journal-title":"Head Neck Pathol"},{"issue":"4","key":"ref10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/08998280.2020.1772029","article-title":"Nasal angiomyolipoma causing persistent nasal congestion","volume":"33","author":"Suresh R","unstructured":"Suresh R, Liu L, Clark D. Nasal angiomyolipoma causing persistent nasal congestion. Proc (Bayl Univ Med Cent). 33(4):644\u20135. 10.1080\/08998280.2020.1772029","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1455613221107735","DOI":"10.1177\/01455613221107735","article-title":"A case of giant nasal septal angiomyolipoma","volume":"5","author":"Liu D","year":"2022","unstructured":"Liu D, An F, Li M, et al. A case of giant nasal septal angiomyolipoma. Ear Nose Throat J Published online August. 2022;5:1455613221107735. 10.1177\/01455613221107735.","journal-title":"Ear Nose Throat J Published online August"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5858\/1999-123-0789-MA","volume":"123","author":"Watanabe K","year":"1999","unstructured":"Watanabe K, Suzuki T, Mucocutaneous, Angiomyolipoma. Arch Pathol Lab Med. 1999;123(9):789\u201392. 10.5858\/1999-123-0789-MA.","journal-title":"Arch Pathol Lab Med"},{"key":"ref13","unstructured":"WHO Classification of Tumours Editorial Board. Skin tumours. Lyon (France): International Agency for Research on Cancer; forthcoming. (WHO classification of tumours series, 5th ed.; vol. 9). https:\/\/publications.iarc.fr"},{"key":"ref14","unstructured":"WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). https:\/\/publications.iarc.fr\/588"},{"key":"ref15","unstructured":"WHO Classification of Tumours Editorial Board. Head and neck tumours. Lyon (France): International Agency for Research on Cancer; 2023. (WHO classification of tumours series, 5th ed.; vol. 9). https:\/\/publications.iarc.who.int\/629"},{"key":"ref16","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 8). https:\/\/publications.iarc.fr\/610"},{"key":"ref17","unstructured":"WHO Classification of Tumours Editorial Board. Digestive system tumours. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumours series, 5th ed.; vol. 1). https:\/\/publications.iarc.fr\/579"},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00428-007-0509-1","article-title":"PEComas: the past, the present and the future","volume":"452","author":"Martignoni G","year":"2008","unstructured":"Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008;452(2):119\u201332. 10.1007\/s00428-007-0509-1.","journal-title":"Virchows Arch"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2559.2005.02316.x","article-title":"PEComa: what do we know so far?","volume":"48","author":"Hornick JL","year":"2006","unstructured":"Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology. 2006;48(1):75\u201382. 10.1111\/j.1365-2559.2005.02316.x.","journal-title":"Histopathology"},{"issue":"5327","key":"ref20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34","volume":"277","author":"Slegtenhorst M","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34. Science. 1997;277(5327):805\u20138. 10.1126\/science.277.5327.805.","journal-title":"Science"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"Identification","year":"1993","unstructured":"Identification. characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75(7):1305\u201315. 10.1016\/0092-8674(93)90618-Z.","journal-title":"Cell"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","article-title":"Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas","volume":"13","author":"Henske EP","year":"1995","unstructured":"Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995;13(4):295\u20138. 10.1002\/gcc.2870130411.","journal-title":"Genes Chromosomes Cancer"},{"key":"ref23","doi-asserted-by":"publisher","author":"Shah PS","unstructured":"Shah PS, Hughes EG, Sukhadia SS et al. Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application. J Mol Diagn. Published online July 6, 2024:S1525-1578(24)00151-X. 10.1016\/j.jmoldx.2024.05.013","DOI":"10.1016\/j.jmoldx.2024.05.013"},{"issue":"10","key":"ref24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions","volume":"34","author":"Argani P","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB, et al. A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions. Am J Surg Pathol. 2010;34(10):1395. 10.1097\/PAS.0b013e3181f17ac0.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-4608(89)90075-7","article-title":"Cytogenetic abnormalities in an angioleiomyoma","volume":"37","author":"Nilbert M","year":"1989","unstructured":"Nilbert M, Mandahl N, Heim S, Rydholm A, Will\u00e9n H, Mitelman F. Cytogenetic abnormalities in an angioleiomyoma. Cancer Genet Cytogenet. 1989;37(1):61\u20134. 10.1016\/0165-4608(89)90075-7.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"ref26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cancergencyto.2010.01.022","article-title":"Angioleiomyoma: a benign tumor with karyotypic aberrations","volume":"199","author":"Welborn J","year":"2010","unstructured":"Welborn J, Fenner S, Parks R. Angioleiomyoma: a benign tumor with karyotypic aberrations. Cancer Genet Cytogenet. 2010;199(2):147\u20138. 10.1016\/j.cancergencyto.2010.01.022.","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"ref27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/gcc.22102","article-title":"Novel MIR143-NOTCH Fusions in Benign and Malignant Glomus Tumors","volume":"52","author":"Mosquera JM","year":"2013","unstructured":"Mosquera JM, Sboner A, Zhang L, et al. Novel MIR143-NOTCH Fusions in Benign and Malignant Glomus Tumors. Genes Chromosomes Cancer. 2013;52(11):1075\u201387. 10.1002\/gcc.22102.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3\u20134","key":"ref28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0165-4608(86)90091-9","article-title":"Structural chromosome aberrations in a case of angioleiomyoma","volume":"20","author":"Heim S","year":"1986","unstructured":"Heim S, Mandahl N, Kristoffersson U, et al. Structural chromosome aberrations in a case of angioleiomyoma. Cancer Genet Cytogenet. 1986;20(3\u20134):325\u201330. 10.1016\/0165-4608(86)90091-9.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0165-4608(96)00070-2","article-title":"An angiomyoma with t(X;10)(q22;q23.2)","volume":"90","author":"Sonobe H","year":"1996","unstructured":"Sonobe H, Ohtsuki Y, Mizobuchi H, Toda M, Shimizu K. An angiomyoma with t(X;10)(q22;q23.2). Cancer Genet Cytogenet. 1996;90(1):54\u20136. 10.1016\/0165-4608(96)00070-2.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"ref30","first-page":"13","article-title":"Chromosomal imbalances in angioleiomyomas by comparative genomic hybridization","volume":"13","author":"Nishio J","year":"2004","unstructured":"Nishio J, Iwasaki H, Ohjimi Y, et al. Chromosomal imbalances in angioleiomyomas by comparative genomic hybridization. Int J Mol Med. 2004;13(1):13\u20136.","journal-title":"Int J Mol Med"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-4608(98)00123-X","article-title":"Karyotype Evolution in a Case of Uterine Angioleiomyoma","volume":"108","author":"Hennig Y","year":"1999","unstructured":"Hennig Y, Caselitz J, Stern C, Bartnitzke S, Bullerdiek J. Karyotype Evolution in a Case of Uterine Angioleiomyoma. Cancer Genet Cytogenet. 1999;108(1):79\u201380. 10.1016\/S0165-4608(98)00123-X.","journal-title":"Cancer Genet Cytogenet"},{"issue":"30","key":"ref32","doi-asserted-by":"publisher","first-page":"48769","DOI":"10.18632\/oncotarget.17953","article-title":"Genetic heterogeneity in leiomyomas of deep soft tissue","volume":"8","author":"Panagopoulos I","year":"2017","unstructured":"Panagopoulos I, Gorunova L, Brunetti M, et al. Genetic heterogeneity in leiomyomas of deep soft tissue. Oncotarget. 2017;8(30):48769\u201381. 10.18632\/oncotarget.17953.","journal-title":"Oncotarget"},{"issue":"7","key":"ref33","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids\u2013their relationship to cytogenetic subgroups","volume":"131","author":"Markowski DN","year":"2012","unstructured":"Markowski DN, Bartnitzke S, L\u00f6ning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids\u2013their relationship to cytogenetic subgroups. Int J Cancer. 2012;131(7):1528\u201336. 10.1002\/ijc.27424.","journal-title":"Int J Cancer"},{"issue":"36","key":"ref34","doi-asserted-by":"publisher","first-page":"JCO2018792549","DOI":"10.1200\/JCO.2018.79.2549","article-title":"Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma","volume":"36","author":"Hsieh JJ","year":"2018","unstructured":"Hsieh JJ, Le VH, Oyama T, Ricketts CJ, Ho TH, Cheng EH. Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma. J Clin Oncol. 2018;36(36):JCO2018792549. 10.1200\/JCO.2018.79.2549.","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref35","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1073\/pnas.0910684107","article-title":"High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset","volume":"107","author":"Car\u00e9n H","year":"2010","unstructured":"Car\u00e9n H, Kryh H, Nethander M, et al. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci U S A. 2010;107(9):4323\u20138. 10.1073\/pnas.0910684107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s0165-4608(99)00252-6","article-title":"Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization","volume":"120","author":"Breen CJ","year":"2000","unstructured":"Breen CJ, O\u2019Meara A, McDermott M, Mullarkey M, Stallings RL. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2000;120(1):44\u20139. 10.1016\/s0165-4608(99)00252-6.","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"ref37","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/2211-5463.13004","article-title":"NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer","volume":"10","author":"Tang L","year":"2020","unstructured":"Tang L, Zhang L, Liu L, et al. NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS Open Bio. 2020;10(12):2678\u201386. 10.1002\/2211-5463.13004.","journal-title":"FEBS Open Bio"},{"issue":"10","key":"ref38","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1093\/nar\/gkv394","article-title":"MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer","volume":"43","author":"Wang C","year":"2015","unstructured":"Wang C, Sun H, Zou R, et al. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Nucleic Acids Res. 2015;43(10):4893\u2013908. 10.1093\/nar\/gkv394.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"ref39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0002-9610(83)90245-3","article-title":"Juvenile nasopharyngeal angiofibroma. A 30 year clinical review","volume":"146","author":"Witt TR","year":"1983","unstructured":"Witt TR, Shah JP, Sternberg SS. Juvenile nasopharyngeal angiofibroma. A 30 year clinical review. Am J Surg. 1983;146(4):521\u20135. 10.1016\/0002-9610(83)90245-3.","journal-title":"Am J Surg"},{"issue":"11","key":"ref40","first-page":"1122","article-title":"Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases","volume":"11","author":"Hwang HC","year":"1998","unstructured":"Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11(11):1122\u20136.","journal-title":"Mod Pathol"},{"issue":"1","key":"ref41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12105-017-0824-z","article-title":"Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features","volume":"12","author":"S\u00e1nchez-Romero C","year":"2018","unstructured":"S\u00e1nchez-Romero C, Carlos R, D\u00edaz Molina JP, Thompson LDR, de Almeida OP, Rumayor Pi\u00f1a A. Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features. Head Neck Pathol. 2018;12(1):52\u201361. 10.1007\/s12105-017-0824-z.","journal-title":"Head Neck Pathol"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12105-020-01251-y","article-title":"THE -OMAS and -OPIAS: Targeted and Philosophical Considerations Regarding Hamartomas, Choristomas, Teratomas, Ectopias, and Heterotopias in Pediatric Otorhinolaryngologic Pathology","volume":"15","author":"Ozolek JA","year":"2021","unstructured":"Ozolek JA, Tekkesin MS. THE -OMAS and -OPIAS: Targeted and Philosophical Considerations Regarding Hamartomas, Choristomas, Teratomas, Ectopias, and Heterotopias in Pediatric Otorhinolaryngologic Pathology. Head Neck Pathol. 2021;15(1):25\u201340. 10.1007\/s12105-020-01251-y.","journal-title":"Head Neck Pathol"},{"issue":"1 Pt 1","key":"ref43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/000348948409300122","article-title":"Pathology consultation. Nomenclature of developmental tumors","volume":"93","author":"Batsakis JG","year":"1984","unstructured":"Batsakis JG. Pathology consultation. Nomenclature of developmental tumors. Ann Otol Rhinol Laryngol. 1984;93(1 Pt 1):98\u20139. 10.1177\/000348948409300122.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"ref44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.bulcan.2018.04.004","article-title":"[WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods]","volume":"105","author":"Sarradin V","year":"2018","unstructured":"Sarradin V, Siegfried A, Uro-Coste E, Delord JP. [WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods]. Bull Cancer. 2018;105(6):596\u2013602. 10.1016\/j.bulcan.2018.04.004.","journal-title":"Bull Cancer"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.humpath.2019.09.018","article-title":"Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas?","volume":"97","author":"Ban\u011b\u010dkov\u00e1 M","year":"2020","unstructured":"Ban\u011b\u010dkov\u00e1 M, Michal M, Laco J, et al. Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas? Hum Pathol. 2020;97:94\u2013102. 10.1016\/j.humpath.2019.09.018.","journal-title":"Hum Pathol"},{"issue":"6","key":"ref46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/jop.13394","article-title":"Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH)","volume":"52","author":"Guimar\u00e3es LM","year":"2023","unstructured":"Guimar\u00e3es LM, Vieira TdaS, De Marco LA, Thompson LDR, Gomes CC. Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH). J Oral Pathol Med. 2023;52(6):548\u201353. 10.1111\/jop.13394.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"ref47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00428-010-0984-7","article-title":"Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases","volume":"457","author":"Ambrosini-Spaltro A","year":"2010","unstructured":"Ambrosini-Spaltro A, Morandi L, Spagnolo DV, et al. Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases. Virchows Arch. 2010;457(6):727\u201334. 10.1007\/s00428-010-0984-7.","journal-title":"Virchows Arch"},{"issue":"5","key":"ref48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/PAS.0000000000002192","article-title":"Pathogenic Somatic Mutation of DICER1 and Clinicopathological Features in Nasal Chondromesenchymal Hamartomas: A Series of Nine Cases","volume":"48","author":"Hu C","year":"2024","unstructured":"Hu C, Liu Y, Lin L, Yuan C, Ma D, Huang Q. Pathogenic Somatic Mutation of DICER1 and Clinicopathological Features in Nasal Chondromesenchymal Hamartomas: A Series of Nine Cases. Am J Surg Pathol. 2024;48(5):588\u201395. 10.1097\/PAS.0000000000002192.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"ref49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2350\/11-11-1121-CR.1","article-title":"Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma","volume":"15","author":"Behery RE","year":"2012","unstructured":"Behery RE, Bedrnicek J, Lazenby A, et al. Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma. Pediatr Dev Pathol. 2012;15(3):249\u201353. 10.2350\/11-11-1121-CR.1.","journal-title":"Pediatr Dev Pathol"},{"issue":"1071","key":"ref50","doi-asserted-by":"publisher","first-page":"20160607","DOI":"10.1259\/bjr.20160607","article-title":"Hamartomas from head to toe: an imaging overview","volume":"90","author":"Leiter Herr\u00e1n F","year":"2017","unstructured":"Leiter Herr\u00e1n F, Restrepo CS, Alvarez G\u00f3mez DI, Suby-Long T, Ocazionez D, Vargas D. Hamartomas from head to toe: an imaging overview. Br J Radiol. 2017;90(1071):20160607. 10.1259\/bjr.20160607.","journal-title":"Br J Radiol"},{"issue":"4","key":"ref51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2500\/ajra.2013.27.3905","article-title":"Sinonasal respiratory epithelial adenomatoid hamartomas: series of 51 cases and literature review","volume":"27","author":"Lee JT","year":"2013","unstructured":"Lee JT, Garg R, Brunworth J, Keschner DB, Thompson LDR. Sinonasal respiratory epithelial adenomatoid hamartomas: series of 51 cases and literature review. Am J Rhinol Allergy. 2013;27(4):322\u20138. 10.2500\/ajra.2013.27.3905.","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"ref52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.tripleo.2010.04.045","article-title":"Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes","volume":"110","author":"Tosios KI","year":"2010","unstructured":"Tosios KI, Koutlas IG, Kyriakopoulos VF, et al. Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 2010;110(4):492\u20137. 10.1016\/j.tripleo.2010.04.045.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843357\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843357\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T20:01:42Z","timestamp":1725825702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843357\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":52,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4843357\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,9,8]]},"subtype":"preprint"}}